Dr. Abdur Razzaque Sarker
Research Fellow (Health Economist)
Profile
Dr. Abdur
Razzaque Sarker is a health economist and researcher from Bangladesh, with
extensive experience in health systems and economic analysis across both
developed and developing nations. Since 2021, Dr. Sarker has consistently been
ranked among Stanford/Elsevier's Top 2% Scientists in the field of Health
Policy & Services.
In 2023, Dr.
Sarker served as a Visiting Research Scholar (May–November) at the Health
Economics Unit, University of Melbourne, Australia. He earned his Ph.D. in
Health Economics and Management Science from the University of Strathclyde,
United Kingdom, with a dissertation focusing on the economics of
vaccine-preventable diseases in lower-middle-income countries. Dr. Sarker has
completed two postgraduate degrees: a Master of Health Economics and a Master
of Economics. Previously, he worked at the University of Birmingham, United
Kingdom; the Mahidol Oxford Tropical Medicine Research Unit (MORU), Thailand;
and ICDDRB, an international public health research organization in Bangladesh.
His research
and academic expertise focus on health systems research, including economic
analysis from various perspectives (patients, households, health systems, and
broader societal perspectives). He has conducted economic evaluations of public
health programs, particularly in the context of vaccine-preventable diseases
(e.g., cholera, malaria, rotavirus, typhoid, dengue, and pneumonia),
non-communicable diseases (e.g., diabetes, hypertension, and cancer), mental
health, quality of life, elder health economics, and healthcare financing
(e.g., out-of-pocket expenditures, catastrophic health burdens, and health
insurance). Dr. Sarker has published over 100 articles in reputed journals,
including BMC, BMJ, PLOS, Public Health, Public
Health Nutrition, and Vaccines. His research has been funded by
prominent organizations such as the Bill & Melinda Gates Foundation, the
University of Basel, the University of Strathclyde, and the Ministries of
Health and Planning.
Other Activities:
· Member
and expertise on health economics issues: Health Economic Analysis and Research
(GEAR) Online Resource. http://gear4health.com/ask-expert
Academic Editor (International)
· BMC
Public Health (Section: Health economics and outcomes research)
· BMC
Health Service Research (Section: Healthcare financing and
economics)
· PLOS
Global Health (Section: Global health)
National
(Board member)
· Bangladesh
Unnoyon Somikkha (Journal)
· Bangladesh
Journal of Administration and Management (Journal)
RESEARCH
PROJECTS:
Ongoing 2025
· Inequality
of out-of-pocket cost across urban and rural Bangladesh
Recently
completed
1) Health
and Financial Burden of Kidney Dialysis in Bangladesh
2) Economic
Burden of Cancer in Bangladesh
3) Economic
Burden of COVID-19 in Bangladesh.
4) Catastrophic Health
Expenditure and its determinants in Bangladesh.
5) Epidemiological
and Economic Burden of Dengue in Dhaka, Bangladesh
6) Covid-19
Vaccine Delivery Barriers in LMICs'
7) Health
status and healthcare seeking behavior assessment among elderly citizen in
Bangladesh
Area of Specialization
- Health Economics and Financing Research
- Recent Study:
- Published: Journal of Infection and Public Health
- Economic assessment of childhood rotavirus vaccination
in Bangladesh
Rotavirus is one of the most highly prevalent
communicable diseases in Bangladesh. The objective of this study is to evaluate
the benefit-cost ratio of childhood rotavirus vaccination program in
Bangladesh. A spreadsheet-based model was used to estimate the benefit and cost
of a nationwide universal rotavirus vaccination program against rotavirus infections among
under-five children in Bangladesh. A benefit-cost analysis was performed to
evaluate a universal vaccination program compared with a status quo. Data from
various published vaccination-related studies and public reports were used. The
introduction of a childhood rotavirus vaccination program in Bangladesh for
14.78 million under-five children is projected to prevent approximately 1.54
million rotavirus cases during the first 2 years including 0.7 million severe
rotavirus infections. This study shows that among the WHO-prequalified rotavirus vaccines, the net societal benefit is the highest if the
vaccination program adopts ROTAVAC® rather than Rotarix® or ROTASIIL®. For
every dollar invested in the outreach-based ROTAVAC® vaccination program,
society would gain $2.03 in return, while in a facility-based vaccination
program, society would gain up to about $2.2. The findings of this study
demonstrate that a universal childhood rotavirus vaccination program is a
cost-beneficial investment of public money. Thus, the government should
consider the introduction of rotavirus vaccination in their Expanded Program on
Immunization since the rotavirus immunization policy in Bangladesh will be
economically justifiable.
Publications
2024
1. Sarker AR, Irfat Zabeen, Hossain Z, Ali
N and Khan JAM (2024). Increasing rate of caesarean birth in Bangladesh: A
household-level pooled analysis. BIRTH. Volume: 51(2) ; doi:
10.1111/BIRT.12789
2. Sarker AR* and Hossain Z (2024). Trends
and inequity of childhood stunting in Bangladesh: A household level analysis. Bangladesh
Development Studies. Vol 45, Nos 3&4
2023
1)
Sarker
AR*, Subrata PauI, Zohara F,
Hossain Z et al (2023). Economic burden of dengue in urban Bangladesh: A
societal perspective. PLOS Neglected Tropical Disease. doi.org/10.1371/journal.pntd.0011820
2)
Sarker
AR (2023). Economic assessment
of childhood rotavirus vaccination in Bangladesh. Journal of Infections
and Public Health.
S1876-0341(23)00102-8
3)
Sarker
AR, Zabeen AI, Hossain Z, Ali N (2023).
Healthcare-seeking experiences of older citizens in Bangladesh: A qualitative
study. PLOS Global Public Health 3(2): e0001185. https://doi.org/10.1371/journal.pgph.0001185
4)
den Boon, S., Ahmed, S. & Sarker AR (2023).
Economic evaluations of immunization programs as an indispensable tool for
policymakers. BMC Health Serv Res 23, 1284 https://doi.org/10.1186/s12913-023-10071-z
5)
Hossain Z, Khanam M, Sarker AR (2023).
Out-of-pocket expenditure among patients with diabetes in Bangladesh: A
nation-wide population-based study. Health Policy OPEN
5(7):100102. DOI 10.1016/j.hpopen.2023.100102
6)
Khanam M and Sarker AR (2023). Determinants and
Inequalities in Dietary Diversity among children aged 6-23 months in
Bangladesh. Bangladesh Development Studies; Vol. XLIV,
September-December 2021, Nos. 3&4
7) Zhang,
M., Kozlowski, H., Chew, R, Sarker AR et al. The
spectrum of health conditions in community-based cross-sectional surveys in
Southeast Asia 2010-21: a scoping review. BMC Public Health 24,
1853 (2024). https://doi.org/10.1186/s12889-024-19347-3
8) Sheikh
N, Sultana M, Sarker AR, Morton A (2023). Equity assessment of maternal
and child healthcare benefits utilization and distribution in public healthcare
facilities in Bangladesh: a benefit incidence analysis. Population Health
Metrics. 21 (2). DOI 10.1186/s12963-023-00312-y
Year 2022
1. Sarker AR, Khan AI, Islam MT, Chowdhury F, Khanam F
et al (2022). Cost of oral cholera vaccine delivery in a mass immunization
program for children in urban Bangladesh. Vaccine: X, 100247. https://doi.org/10.1016/j.jvacx.2022.100247.
2. Sarker AR*, Zabeen AI, Hossain Z, Ali N (2022). Inequality
of Handwashing Practice using Antimicrobial Agents in Bangladesh: A household
level analyses. Public Health. Dec 20;214:106-115.
https://doi.org/10.1016/j.puhe.2022.11.011
3. Sarker AR*, Hossain Z, Morton A. Drivers and
distribution of the household-level double burden of malnutrition in
Bangladesh: analysis of mother-child dyads from a national household
survey. Public
Health Nutrition. 2022 Sep 16:1-14.
https://doi.org/10.1017/S1368980022002075
4. Sarker AR*, Ali Z, Ahmed M, Ali N (2022).
Out-of-pocket payment for healthcare among urban citizens in Dhaka,
Bangladesh. PLOS ONE. 17(1):
e0262900.
https://doi.org/10.1371/journal.pone.0262900
5. Sarker AR* and Hossain Z (2022). The Progress
and Factors of Childhood Severe, Moderate and Global Acute Malnutrition in
Bangladesh over 22 years: Evidence from Demography and Health Survey. Bangladesh Development Studies. Vol XLIV, Nos 1&2
6. Sheikh N, Sarker AR, Sultana M et al
(2022). Disease‑specific distress healthcare financing and
catastrophic out‑of‑pocket expenditure for hospitalization in Bangladesh. International Journal for Equity in Health. 21:114 https://doi.org/10.1186/s12939-022-01712-6
7. Rahman MA, Anan T, Sarker AR, Mehareen J. (2022).
Validity and reliability of the Patient Health Questionnaire Scale (PHQ-9)
among university students of Bangladesh. Accepted in PLoS ONE.
Year 2021
1. Sarker AR* (2021). Health-related quality of life among older citizens in Bangladesh. SSM-Mental Health. 2021 Vol.1 100031. https://doi.org/10.1016/j.ssmmh.2021.100031
2. Sarker AR* and Khanam M (2021). Socio‑economic inequalities in diabetes and prediabetes among Bangladeshi adults. Diabetology International. https://doi.org/10.1007/s13340-021-00556-9
3. Sarker AR*, Sultana M, Alam K and Morton A (2021). Households' out-of-pocket expenditure for healthcare in Bangladesh: A financing incidence analysis. International Journal of Health Planning and Management. (2021), p 1-12, DOI: 10.1002/hpm.3275
4. Ahmed S, Dorin F, Moinuddin S, Sarker AR et al (2021). The economic burden of rotavirus hospitalization among children < 5 years of age in selected hospitals in Bangladesh. Vaccine: 2021. doi:10.1016/j.vaccine.2021.10.003
5. Colson A, Morton A, Ardal C, Chalkidou,K, Davies S, Garrison L, Jit M, Laxminarayan R, Megiddo I, Morel C, Nonvignon J, Outterson K, Rex J, Sarker AR, Sculpher M, Wood B, Xiao W (2021). Antimicrobial Resistance: Is Health Technology Assessment Part of the Solution or Part of the Problem? Value in Health. Sep 2021. DOI: 10.1016/j.jval.2021.06.002
6. Tagoe ET, Sheikh N, Morton A, Nonvignon J, Sarker AR, Williams L and Megiddo I (2021) COVID-19 Vaccination in Lower-Middle Income Countries: National Stakeholder Views on Challenges, Barriers, and Potential Solutions. Frontiers in Public Health 9:709127. doi: 10.3389/fpubh.2021.709127
7. Mehareen J, Anan D, Rahman M and Sarker AR (2021). Prevalence and socio-demographic correlates of depression, anxiety, and co-morbidity during COVID-19: A cross-sectional study among public and private university students of Bangladesh. Journal of Affective Disorders Reports.5 (2021)100179.
8. Khanam M, Hasan E and Sarker AR (2021). Prevalence and Factors of Hypertension among Bangladeshi Adults. High Blood Pressure & Cardiovascular Prevention. https://doi.org/10.1007/s40292-021-00461-x
9. Murshid KAS, Mahmood T, Azaz N, Sarker AR (2021). COVID-19 in Bangladesh: Prevalence, KAP and Heterogeneous Shocks under 'General Holiday' - An Exploratory Study Based on an Online Survey. The Bangladesh Development Studies (Accepted).
10. Sarker AR and Ali N (2021). Status of handwashing with microbial agents and COVID-19 pandemic in Bangladesh (Bangla article). Bangladesh Unnoyon Somikkha. Volume 38:1426
11. Paulson KR, Kamath AM, Alam T, Bienhoff K, Abady G et al (2021). Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019. The Lancet. https://doi.org/10.1016/S0140-6736(21)01207-1
1. Sarker AR* and Sultana M (2020). Cost-effectiveness of childhood malaria vaccination in endemic hotspots of Bangladesh. PLOS ONE 15(5):e0233902
2. Sarker AR*, Islam Z, Morton A, Khan JAM et al (2020). Willingness to Pay for Cholera Vaccine in Bangladesh. PLOS ONE 15(4): e0232600
3. Sarker AR, Ali N, Akram R, Sultana M (2020). Economic loss due to diarrheal infection in Bangladeshi households (Bangla article). Bangladesh Unnoyon Somikkha. Volume 37:1426
4. Akram R, Sarker AR, Ali Ni, Sheikh N, MGN Mozumder, Sultan M (2020). Factors associated with unmet fertility desire and perceptions of ideal family size among women in Bangladesh: Insights from a nationwide Demographic and Health Survey. PLOS ONE, 15(5)
5. Ahmed S, Sarker AR, Sultana M, Roth F, Mahumud RA, Hasan Z, et al (2020). Do employer- sponsored health insurance schemes affect the utilisation of medically trained providers and out- of- pocket payments among ready- made garment workers? A case–control study in Bangladesh. BMJ Open. 2020; 10. doi:10.1136/bmjopen-2019-030298
6. Mahumud RA, Gow J, Sarker AR, Sultana M, Alam K, (2020). Distribution of wealth-stratified inequalities on maternal and child health parameters and influences of maternal-related factors on improvements in child health survival rate in Bangladesh. Journal of Child Health Care. 2020.XX Vol (I).
7. Reiner RC, Hay SI, Reiner RC, Wiens KE, Deshpande A, Baumann MM, et al (2020). Mapping geographical inequalities in childhood diarrhoeal morbidity and mortality in low-income and middle-income countries, 2000–17: analysis for the Global Burden of Disease Study 2017. Lancet. 2020; 6736:1–23. doi:10.1016/S0140-6736(20)30114-8.
8. Kinyoki, DL, Ross JM, Munro S, Schaeffer L and GBD et al (2020). Mapping local patterns of childhood overweight and wasting in low- and middle-income countries between 2000 and 2017. Nature Medicine. doi:10.1038/s41591-020-0807-6.
9. James SL, Castle CD, Dingels ZV, Fox JT and GBD et al (2020). Global injury morbidity and mortality from 1990 to 2017: results from the Global Burden of Disease Study 2017. Injury Prevention. doi:10.1136/injuryprev-2019-043494
10. Franklin RC, Peden AE, Hamilton EB, Bisignano C, Sarker AR, Castle CD, Dingels Z V, et al (2020). The burden of unintentional drowning: global, regional and national estimates of mortality from the Global Burden of Disease 2017 Study. Injury Prevention. Injury Prevention. Doi: 10.1136/injuryprev-2019-043484
11. James SL, Castle CD, Dingels Z V, Fox JT, Hamilton EB, Liu Z, et al
(2020). Estimating global injuries morbidity and mortality: methods and data
used in the Global Burden of Disease 2017 study. Injury Prevention; 1–29.
doi:10.1136/injuryprev-2019-04353.
12. Wiens K. E, Lindstedt P.A, Blacker F.
A, Johnson K.B, Baumann M, Schaeffer L, Abbastabar H and GBD et al
(2020). Mapping geographic inequalities in oral rehydration therapy
coverage in low-income and middle-income countries, 2000-17. The Lancet Global Health, 2020 8(8):e1038-1060.
2019
1. Sarker AR*, Sultana M, Akram R Ali N, Morton A (2019). Socio-economic inequality of childhood undernutrition in Bangladesh: A decomposition approach. International Journal of Health Planning and Management. November 08, DOI: 10.1002/hpm.2918
2. Sarker AR*, Akram R Ali N, Sultana M (2019). Coverage and determinants of full immunization coverage among children aged 12 to 59 months in Bangladesh. BMJ Open; 9:e028020. doi:10.1136/bmjopen-2018-028020
3. Sarker AR*, Sultana M, Ali N, Akram R, Alam K, Khan JAM, Morton A (2019). Cost of caregivers for treating hospitalized diarrheal patients in Bangladesh. Tropical Medicine and Infectious Disease, 4(5) doi:10.3390/tropicalmed4010005
4. Sarker AR*, Akram R, Ali N, Islam Z, Sultana M (2019). Coverage and Determinants of Full Immunization : Vaccination Coverage among Senegalese Children. Medicina 55(8), 480; doi:10.3390/medicina55080480
5. Sultana M, Sarker AR, Ali N, Akram R and Gold L (2019) Economic evaluation of community acquired pneumonia management strategies: A systematic review of literature. Plos One. 14(10): e0224170.
6. Mahumud RA, Alam K, Gow J, Sarker AR, Sultana M (2019). Cost-effectiveness of the introduction of two-dose bi-valent (Cervarix) and quadrivalent (Gardasil) HPV vaccination for adolescent girls in Bangladesh. Vaccine 38(2):165-172 DOI: 10.1016/j.vaccine.2019.10.037
7. Mahumud RA, Ali N, Sheikh N, Akram R, Alam K, Gow J, Sarker AR, Sultana M (2019). Measuring perinatal and postpartum quality-of-life of women and associated factors in semi-urban Bangladesh. Quality of Life Research. doi.org/10.1007/s11136-019-02247-0
8. Sultana M, Sarker AR, Ali N, Akram R et al (2019). Prevalence, determinants and health care seeking behavior of acute respiratory tract infections (ARIs) among under-five children in Bangladesh. PLoS ONE 14(1): e0210433
9. Sultana M, Akram R, Ali N, Mahumud RA, and Sarker AR, Islam Z (2019). Group Prenatal Care experiences among pregnant women in a Bangladeshi community. PLoS ONE 14(6): e0218169
10. Mahumud RA, Alam K, Renzaho A, Sarker AR, Sultana M, Sheikh N, Rawal LB, Gow Jeff Changes in inequality of childhood morbidity in Bangladesh 1993-2014: A decomposition analysis. PLoS ONE 14(6):e0218515
11. Sheikh N, Ali N, Akram R, Mahumud RA, Sarker AR, Sultana M (2019). Infant and young child feeding practice, dietary diversity and child health in Bangladesh. Journal of Child Health. PP 1-14.
12. Ali N, Akram R, Sheikh N, Sarker AR, Sultana M (2019). Sex-specific prevalence, inequality, and associated predictors of hypertension, diabetes, and comorbidity among Bangladeshi adults: Results from a nationwide cross-sectional demographic and health survey. BMJ Open; 9:e029364. doi:10.1136/bmjopen-2019-029364
13. Khanam M, Shimul SN, Sarker AR* (2019). Individual, Household and Community Level Determinants of Childhood Under-nutrition in Bangladesh. Health Services Research & Managerial Epidemiology; volume 6, pp 1-12,
14. Alam K, Mahumud RA, Alam F, Keramat A, Sarker AR (2019). Determinants of access to eHealth services in regional Australia. International Journal of Medical Informatics; 131 (103960).doi.10.1016/j.ijmedinf.2019.103960
15. Khan JAM, Ahmed S, Sultana M, Sarker AR, Nissen L (2019). Impact of Community-Based Health Insurance for Informal Workers on OOP Payments for Healthcare from Medically Trained Providers - Evidence from Bangladesh for the Journey towards Universal Health Coverage. International Health; 00: 1–12,
2018
1. Sarker AR* Sultana M, Ali N, Akram R, Sheikh N, Mahumud RA and Morton A (2018). Cost-comparison and determinants of out-of-pocket payments on child delivery care in Bangladesh International Journal of Health Planning and Management, DOI: 10.1002/hpm.2615, 1-18
2. Sarker AR*, Sultana M, Ahmed S, Mahumud RA, Morton A, Khan JAM (2018). Clients' experience and satisfaction with healthcare services in a Community Based Health Insurance Program in Bangladesh. International Journal of Environmental Research and Public Health 15(8), 1637: 1-14
3. Sarker AR*, Sultana M, Mahumud RA et al (2018). Economic costs of hospitalized diarrheal disease in Bangladesh: A societal perspective. BMC Global Health Research and Policy 3 (1):1-12
4. Sarker AR*, Sheikh N, Mahumud RA, Sultana M (2018). Determinants of adolescent maternal healthcare utilization in Bangladesh. Public Health. 157: 94-103
5. Akram R, Sultana M, Sheikh N, Ali N, Sarker AR* (2018). Prevalence and determinants of stunting among preschool children and its urban rural disparities in Bangladesh. Food and Nutrition Bulletin DOI: 10.1177/0379572118794770, pp 1-15
6. Sheikh N, Sultana M, Ali N, Akram R, Mahumud RA, Asaduzzaman M, Sarker AR* (2018) Coverage, timelines and determinants of incomplete immunization in Bangladesh. Tropical Medicine and Infectious Disease, 2018, 3(3), 72: 1-14
7. Ali N, Sultana M, Sheikh N, Akram R, Mahumud RA, Asaduzzaman M, Sarker AR* (2018). Predictors of optimal antenatal care service utilization among adolescents and adult women in Bangladesh. Health Services Research & Managerial Epidemiology, 2018, Volume 5: 1-8
8. Ahmed S, Sarker AR, Sultana M, Chakrovorty S, Hasan MZ, Mirelman AJ, et al (2018). Adverse Selection in Community Based Health Insurance among Informal Workers in Bangladesh: An EQ-5D Assessment. International Journal of Environmental Research and Public Health. 2018; 15 (2):1–10.
9. Ahmed S, Sarker AR, Sultana M, Islam Z, Rukhsana G, Khan JAM (2017). The Impact of Community-Based Health Insurance on the Utilization of Medically Trained Healthcare Providers among Informal Workers in Bangladesh. PLoS ONE 13(7): e0200265.
10. Khan AI, Levin A, Chao D, DeRoeck D, Dimitrov D, Khan JAM, Islam MS, Ali M, Islam T, Sarker AR, Clemens J, Qadri F (2018). The impact and cost-effectiveness of controlling cholera through the use of oral cholera vaccines in urban Bangladesh: a disease modelling and economic analysis. PLOS Neglected Tropical Diseases 12(10): e0006652.
11. Godói IP, Silva LV, Sarker AR, Megiddo I, Morton A, GodmanB, Alvarez-Madrazo S, Bennie M and Guerra AA (2018). Economic and epidemiological impact of dengue illness over sixteen years from a public health system perspective in Brazil to inform future health policies including the adoption of a dengue vaccine. Expert Review of Vaccines; 17(12): 1123-1133.
2017
1. Sarker AR*, Sultana M, Mahumud RA, Meer RVD, and Morton A (2017). Cost-effectiveness analysis of introducing universal childhood rotavirus vaccination in Bangladesh. Human Vaccines & Immunotherapeutics. 14(1):189-198.
2. Sarker AR* and Sultana M (2017). Health and economic burden of diabetes in Bangladesh: Priorities for Attention and Control. Journal of Diabetes 9 (12):1118-1119
3. Sarker AR*, Sultana M, Mahumud RA, Ahmed S, Morton A, Khan JAM (2017). Determinants of enrolment of informal sector workers in cooperative based health scheme in Bangladesh. PLoS ONE 12(7): e0181706.
4. Sultana M, Mahumud RA, Ahmed S, Islam Z, Khan JAM, Sarker AR (2017). Cost of Introducing Group Prenatal Care (GPC) in Bangladesh: a supply side perspective. Safety in Health 3 (8):1-8
5. Sultana M, Mahumud RA and Sarker AR (2017). Burden of chronic illness and associated disabilities in Bangladesh: Evidence from Household Income and Expenditure survey. Chronic Diseases and Translational Medicine 3: 112-122
6. Sultana M, Sheikh N, Mahumud RA, Jahir T, Islam Z and Sarker AR (2017). Prevalence and associated determinants of malaria parasites among children in Kenya. Tropical Medicine and Health 45:25;1-9
7. Mahumud RA, Sultana M and Sarker AR (2017). Prevalence and associated determinants of low birth weight in developing countries: A multi-country analysis from nationwide population-based survey. Journal of Preventive Medicine and Public Health 50:18-28
8. Mahumud RA, Sarker AR, Sultana M, Ahmed S, Khan JAM, Morton A, (2017). Distribution and Determinants of Out-of-pocket Healthcare Expenditures in Bangladesh. Journal of Preventive Medicine and Public Health 50 (2):91-99
9. Sultana M, Mahumud RA, Ahmed S, Islam Z, Khan JAM, Sarker AR (2017). The effectiveness of introducing Group Prenatal Care (GPC) in selected health facilities in a district of Bangladesh: study protocol. BMC Pregnancy and Childbirth. 17 (48) DOI 10.1186/s12884-017-1227-6
2016
1. Sarker AR*, Sultana M, Mahumud RA, Nurnabi S, Meer RVD, Morton A (2016). Prevalence and healthcare-seeking behaviour for childhood diarrheal disease in Bangladesh. Global Pediatric Health. Volume 1(3) pp 1-12; doi: 10.1177/2333794X16680901
2. Sarker AR*, Sultana M, Mahumud RA (2016). Co-operative Societies: A sustainable platform for promoting universal health coverage in Bangladesh. BMJ Global Health. Volume 1(3) 2016; 1:e000052. doi:10.1136/bmjgh-2016-000052
3. Sarker AR*, Sultana M, Mahumud RA, Ahmed S, Ahmed W et al (2016). Occupational illness on labor productivity: A socio-economic aspect of informal sector workers in urban Bangladesh. Journal of Occupational Health. Volume 58(2):209-15
4. Sultana M, Sarker AR, Mahumud RA, Ahmed S, Ahmed W, Chakrovorty S, Rahman H, Islam Z, Khan JAM (2016). Inequalities in health status among low income communities: EQ-5D findings from household survey in selected communities of Bangladesh. International Journal of Health Policy and Management. Volume 5 (3) 1-8.
5. Khan JAM, Ahmed S, Sarker AR, Sultana M et al (2016). Benefit Incidence Analysis of Healthcare in Bangladesh – Equity Matters for Universal Health Coverage. Health Policy and Planning. Volume 2016:1 Pages 1–7.
6. Ahmed S, Hoque ME, Sarker AR, Sultana M, Islam Z, Rukhsana G, Khan JAM (2016). Willingness-to-Pay for Community-Based Health Insurance among Informal Workers in Urban Bangladesh. PLoS ONE. Volume 11(2): e0148211.
7. Sultana M, Mahumud RA, Sarker AR, Hossain SM (2016). Hand hygiene knowledge and practice among university students: evidence from Private Universities of Bangladesh. Risk Management and Healthcare Policy. Volume 2016:9 Pages 13—20.
2015
1. Sarker AR*, Islam Z, Khan IA, Saha A, Chowdhury F, Khan AI, Cravioto A, Clemens JD, Qadri F, Khan JAM (2015). Estimating the cost of cholera-vaccine delivery from the societal point of view: A case of introduction of cholera vaccine in Bangladesh. Vaccine. Volume 11; 33 (38): 4916-21.
2. Islam Z, Sarker AR*, Anwar S, Kabir H, Gazi R (2015). Costs of integrating demand based reproductive health commodity model into the Government and NGO service delivery systems in Bangladesh: a supply side perspective. SpringerPlus. Volume 4:808.
3. Mahumud RA, Sultana M, Sarker AR (2015). Trend of Healthcare Expenditures in Bangladesh over Last Decades. American Journal of Economics, Finance and Management. Volume. 1, Issue 3, pp. 97-101.
4. Mahmud RA, Hossain MG, Sarker AR, Islam MN, Hossain MR, Aik S, Khan JAM (2015). Prevalence and associated factors of contraceptive discontinuation and switching among Bangladeshi women of reproductive age. Open Access Journal of Contraception. Volume 6:13-19.
2014
1. Sarker AR*, Mahumud RA, Sultana M, Ahmed S, Ahmed W, Khan JAM (2014). The impact of age and sex on healthcare expenditure of households in Bangladesh. SpringerPlus 3:435.
2. Sarker AR*, Islam Z, Khan IA, Saha A, Chowdhury F, Khan AI, Qadri F, Khan JAM (2013). Cost of Illness for Cholera in a High-Risk Urban Area in Bangladesh: An Analysis from Household Perspective. BMC Infectious Diseases 13 (1), 518.
3. Sarker AR*, Khan JAM (2013). Informal Workers in Bangladesh: An Analysis from socio-economic perspective. Asian journal of research in business economics and management. Volume 3, Issue 6
The Lancet Series -2018, Role: Collaborator
1. Dieleman JL, Sadat N, Chang AY, Fullman N, Abbafati C, Acharya P, et al (2018). Trends in future health financing and coverage: future health spending and universal health coverage in 188 countries, 2016–40. The Lancet. 2018; 6736.
2. Dieleman JL, Haakenstad A, Micah A, Moses M, Abbafati C, Acharya P, et al (2018). Spending on health and HIV/AIDS : domestic health spending and development assistance in 188 countries, 1995- 2015. The Lancet. 2018; 6736.
3. Fullman N, Yearwood J, Abay SM, Abbafati C, Abd-Allah F, Abdela J, et al (2018). Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016. The Lancet. 2018
4. GBD 2016 Alcohol Collaborators (2018). Alcohol use and burden: a systematic analysis from the Global Burden of Disease Study 2016 for 195 countries and territories, 1990-2016. The Lancet; 2018;6736: 1–21.
5. GBD Disease and Injury Incidence and Prevalence Collaborators (2018). Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016. The Lancet. 2017;390: 1211–1259
6. GBD 2017 DALYs and HALE Collaborators (2018).GBD Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet 2018; 392: 1684–735
7. GBD 2017 Mortality Collaborators (2018). Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet 2018; 392: 1684–735
8. GBD 2017 Causes of Death Collaborators (2018). Global, regional, and national age-sex-specific mortality for282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet 2018; 392: 1736–88
9. GBD 2017 Risk Factor Collaborators (2018). Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet 2018; 392: 1923–94
10. GBD 2017 SDG Collaborators 92018). Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet 2018; 392: 2091–138
11. GBD 2017 Disease and Injury Incidence and Prevalence Collaborators (2018). Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. 2018; The Lancet 392: 1789–858
12. GBD 2017 Population and Fertility Collaborators (2018). Population and fertility by age and sex for 195 countries and territories, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet 2018; 392: 1995–2051
